DECIBEL CANNABIS CO INC (DB.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:DB • CA2434371001

0.09 CAD
0 (0%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

4

DB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Pharmaceuticals industry. DB has a medium profitability rating, but doesn't score so well on its financial health evaluation. DB is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • DB had negative earnings in the past year.
  • DB had a positive operating cash flow in the past year.
  • In multiple years DB reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: DB reported negative operating cash flow in multiple years.
DB.CA Yearly Net Income VS EBIT VS OCF VS FCFDB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • With an excellent Return On Assets value of 7.97%, DB belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
  • DB's Return On Equity of 18.35% is amongst the best of the industry. DB outperforms 90.91% of its industry peers.
Industry RankSector Rank
ROA 7.97%
ROE 18.35%
ROIC N/A
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
DB.CA Yearly ROA, ROE, ROICDB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

  • DB has a better Profit Margin (10.67%) than 81.82% of its industry peers.
  • In the last couple of years the Profit Margin of DB has grown nicely.
  • DB's Gross Margin of 21.98% is on the low side compared to the rest of the industry. DB is outperformed by 69.70% of its industry peers.
  • In the last couple of years the Gross Margin of DB has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 10.67%
GM 21.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
DB.CA Yearly Profit, Operating, Gross MarginsDB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

3

2. Health

2.1 Basic Checks

  • DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DB has been increased compared to 1 year ago.
  • The number of shares outstanding for DB has been increased compared to 5 years ago.
  • Compared to 1 year ago, DB has an improved debt to assets ratio.
DB.CA Yearly Shares OutstandingDB.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
DB.CA Yearly Total Debt VS Total AssetsDB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • DB has an Altman-Z score of 0.89. This is a bad value and indicates that DB is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of DB (0.89) is better than 69.70% of its industry peers.
  • The Debt to FCF ratio of DB is 18.67, which is on the high side as it means it would take DB, 18.67 years of fcf income to pay off all of its debts.
  • DB has a Debt to FCF ratio of 18.67. This is in the better half of the industry: DB outperforms 69.70% of its industry peers.
  • DB has a Debt/Equity ratio of 0.54. This is a neutral value indicating DB is somewhat dependend on debt financing.
  • DB has a worse Debt to Equity ratio (0.54) than 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 18.67
Altman-Z 0.89
ROIC/WACCN/A
WACC7.99%
DB.CA Yearly LT Debt VS Equity VS FCFDB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • DB has a Current Ratio of 1.34. This is a normal value and indicates that DB is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of DB (1.34) is worse than 60.61% of its industry peers.
  • DB has a Quick Ratio of 1.34. This is a bad value and indicates that DB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.61, DB is doing worse than 78.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 0.61
DB.CA Yearly Current Assets VS Current LiabilitesDB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 816.22% over the past year.
  • Measured over the past years, DB shows a very strong growth in Earnings Per Share. The EPS has been growing by 90.70% on average per year.
  • DB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.11%.
  • DB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 71.51% yearly.
EPS 1Y (TTM)816.22%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%36.51%

3.2 Future

  • DB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.68% yearly.
  • The Revenue is expected to grow by 10.49% on average over the next years. This is quite good.
EPS Next Y100%
EPS Next 2Y101%
EPS Next 3Y71.68%
EPS Next 5YN/A
Revenue Next Year25.36%
Revenue Next 2Y22.27%
Revenue Next 3Y19.18%
Revenue Next 5Y10.49%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DB.CA Yearly Revenue VS EstimatesDB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
DB.CA Yearly EPS VS EstimatesDB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 2026 2027 0 -0.05 -0.1 -0.15

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Forward Earnings ratio of 4.41, the valuation of DB can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, DB is valued cheaply inside the industry as 93.94% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, DB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.41
DB.CA Price Earnings VS Forward Price EarningsDB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • DB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DB is cheaper than 69.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.18
EV/EBITDA N/A
DB.CA Per share dataDB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15

4.3 Compensation for Growth

  • DB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as DB's earnings are expected to grow with 71.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y101%
EPS Next 3Y71.68%

0

5. Dividend

5.1 Amount

  • No dividends for DB!.
Industry RankSector Rank
Dividend Yield 0%

DECIBEL CANNABIS CO INC

TSX-V:DB (2/6/2026, 7:00:00 PM)

0.09

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-19
Earnings (Next)04-20
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.84%
Ins Owner ChangeN/A
Market Cap51.92M
Revenue(TTM)109.31M
Net Income(TTM)11.66M
Analysts82
Price Target0.27 (200%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.87%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)7.97%
Revenue beat(4)1
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-13.84%
Max Revenue beat(4)7.97%
Revenue beat(8)2
Avg Revenue beat(8)-5.36%
Revenue beat(12)5
Avg Revenue beat(12)1.08%
Revenue beat(16)5
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-100%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)-4.61%
Revenue NQ rev (3m)-13.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.41
P/S 0.47
P/FCF 21.18
P/OCF 13.12
P/B 0.82
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0.02
Fwd EY22.67%
FCF(TTM)0
FCFY4.72%
OCF(TTM)0.01
OCFY7.62%
SpS0.19
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 18.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.67%
GM 21.98%
FCFM 2.24%
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 18.67
Debt/EBITDA N/A
Cap/Depr 23.63%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 21.01%
Current Ratio 1.34
Quick Ratio 0.61
Altman-Z 0.89
F-Score6
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)70.46%
Cap/Depr(5y)95.47%
Cap/Sales(3y)2.65%
Cap/Sales(5y)5.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)816.22%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y100%
EPS Next 2Y101%
EPS Next 3Y71.68%
EPS Next 5YN/A
Revenue 1Y (TTM)15.11%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%36.51%
Revenue Next Year25.36%
Revenue Next 2Y22.27%
Revenue Next 3Y19.18%
Revenue Next 5Y10.49%
EBIT growth 1Y-65.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year310.35%
EBIT Next 3Y86.3%
EBIT Next 5Y46.87%
FCF growth 1Y-16.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.82%
OCF growth 3YN/A
OCF growth 5YN/A

DECIBEL CANNABIS CO INC / DB.CA FAQ

What is the ChartMill fundamental rating of DECIBEL CANNABIS CO INC (DB.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to DB.CA.


What is the valuation status of DECIBEL CANNABIS CO INC (DB.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to DECIBEL CANNABIS CO INC (DB.CA). This can be considered as Fairly Valued.


How profitable is DECIBEL CANNABIS CO INC (DB.CA) stock?

DECIBEL CANNABIS CO INC (DB.CA) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for DB stock?

The Earnings per Share (EPS) of DECIBEL CANNABIS CO INC (DB.CA) is expected to grow by 100% in the next year.